g1therapeutics.com

G1 Therapeutics, Inc.

G1 Therapeutics, Inc.'s email is info@g1therapeutics.com and G1 Therapeutics, Inc.'s phone number is (919) 213-9835 .

G1 Therapeutics is a clinical-stage company developing novel cancer therapies. It was founded in 2008 by Drs. Norman Sharpless and Kwok-Kin Wong to capitalize on discoveries made and patented by Dr. Sharpless’ lab at the University of North Carolina at Chapel Hill, and subsequently licensed to G1 Therapeutics. Trilaciclib is an investigational therapy designed to improve outcomes for people with cancer who are treated with chemotherapy. G1 is also advancing rintodestrant, a potential best-in-class oral selective estrogen receptor degrader, or SERD, for the treatment of ER+ breast cancer.
View Top Employees for G1 Therapeutics, Inc.
img Website g1therapeutics.com
img Industry Biotechnology
img Location North Carolina, United States
img Employees 121
img Founded 2012
img HQ 79 T.W. Alexander Dr. 4401 Research Commons, Suite 105
img Phone (919) 213-9835
img Email info@g1therapeutics.com
img Funding 497,318,007 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website g1therapeutics.com
img Industry Biotechnology
img Location North Carolina, United States
img Employees 121
img Founded 2012
img LinkedIn linkedin.com/company/g1-therapeutics-inc-
img HQ 79 T.W. Alexander Dr. 4401 Research Commons, Suite 105
img Phone (919) 213-9835
img Email info@g1therapeutics.com
img Funding 497,318,007 USD

Top G1 Therapeutics, Inc. Employees